{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-051267","form_type":"8-K","ticker":"RMTI","cik":"0001041024","company_name":"ROCKWELL MEDICAL, INC.","filed_at":"2025-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.627994+00:00","generated_at":"2026-05-16T20:49:30.489969+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Rockwell Medical Q3 net sales fall 44% to $15.9M; net loss of $1.8M vs profit year ago","bullets":["Net sales $15.9M, down 44% YoY due to largest customer transitioning to another supplier.","Net loss of $1.8M compared to net income of $1.7M in Q3 2024; Adjusted EBITDA virtually breakeven at $50k.","Gross margin contracted to 14% (18% excluding restructuring) from 22% a year ago.","Cash increased to $23.7M from $18.4M at June 30, driven by ATM stock issuance.","Reaffirms 2025 guidance: net sales $65-70M, gross margin 16-18%, Adjusted EBITDA ($0.5M)-$0.5M."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-051267","json":"https://secwatch.observer/filing/0001628280-25-051267.json","markdown":"https://secwatch.observer/filing/0001628280-25-051267.md","text":"https://secwatch.observer/filing/0001628280-25-051267.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1041024/000162828025051267/0001628280-25-051267-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1041024/000162828025051267/rmti-20251112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T20:49:30.489969+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}